To be able to use the full range of Shopware 6, we recommend activating Javascript in your browser.

HCMV pp65 16-24 (HLA-A*11:01)
( GPISGHVLK )

HCMV pp65 (16-24) peptide GPISGHVLK (HLA-A*11:01) for stimulation of human CMV pp65 (16-24)-specific CD8+ T-cells.

Sequence:	GPISGHVLK
Gene:	UL83
Delivery:	1-3 days
C-Terminus:	OH
N-Terminus:	H
Amount:	1 mg
Counter Ion:	TFA
Protein:	65 kDa phosphoprotein
Species:	Human cytomegalovirus (Human herpesvirus 5)
Allele:	HLA-A*11:01
Application :	T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication :	Infectious disease, Cancer, Neuroscience, Diabetes
Purity :	95% HPLC-MS

Protocols and Tips

Handling peptides

Data sheets

Safety data sheet poly peptides:

Do you have any questions concerning this product?

Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >

€63.50*

Prices excl. VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS

Amount in mg

1 mg

5 mg

Product number: EP06165_1

More HCMV pp65 peptides

HCMV pp65 113-121 (HLA-A*24:02) ( VYALPLKML )

Antigen Peptide HCMV pp65 (113-121) HLA-A*24:02 (VYALPLKML) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. VYALPLKML is a linear peptidic epitope (epitope ID 71976) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €63.50*

HCMV pp65 123-131 (HLA-B*35:01) ( IPSINVHHY )

CMV-derived peptide of IPSINVHHY sequence covering 123-131 and B*35:01 molecule. IPSINVHHY is a linear peptidic epitope (epitope ID 28061) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €63.50*

HCMV pp65 16-24 (HLA-A*11:01) ( GPISGHVLK )

HCMV pp65 (16-24) peptide GPISGHVLK (HLA-A*11:01) for stimulation of human CMV pp65 (16-24)-specific CD8+ T-cells.

From €63.50*

HCMV pp65 265-275 (HLA-B*07:02) ( RPHERNGFTVL )

RPHERNGFTVL is a linear peptidic epitope (epitope ID55170) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €63.50*

HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) ( QYDPVAALF )

HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) QYDPVAALF for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. QYDPVAALF is a linear peptidic epitope (epitope ID52886) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €63.50*

HCMV pp65 363-373 (HLA-A*01:01) ( YSEHPTFTSQY )

YSEHPTFTSQY is a linear peptidic epitope (epitope ID75718) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €63.50*

HCMV pp65 417 – 426 (HLA-B*07:02) ( TPRVTGGGAM )

Antigen Peptide CMV pp65 - HLA-B*07:02 (TPRVTGGGAM) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. CMV pp65 (415-429) (HLA-B7) is a CEF control peptide that is derived from the Cytomegalovirus (CMV). CMV is capable of infecting a wide range of human cell types, where the body’s primary immune response to CMV is innate, and relies on inflammatory cytokines and costimulatory molecules in order to control the spread of the virus. CMV pp65 (415-429) (HLA-B7) is defined as a CEF control peptide due to its antigenic properties. Clinically, these peptides are suitable epitopes for CD8+ T cells and can be used to stimulate the release of IFNg. HLA-B7 refers to the cell HLA type that this peptide acts on.

From €126.80*

Tip

HCMV pp65 495-503 (HLA-A*02:01) ( NLVPMVATV )

Linear peptidic epitope (NLVPMVATV; epitope ID44920) for the stimulation of human CMV-specific CD8+ T-cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The synthesized peptide is presented by the MHC class I HLA-A*0201 allele. NLVPMVATV is part of the 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus).

From €63.50*

HCMV pp65 512-521 (HLA-B*44:02) ( EFFWDANDIY )

EFFWDANDIY is a linear peptidic epitope (epitope ID11995) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays

From €63.50*

Tip

HCMVA pp65 Peptide Pool

Peptide Pool of 138 peptides derived from a peptide scan (15mers with 11 aa overlap) through 65 kDa phosphoprotein (pp65) (UniProtKB - P06725) of Human cytomegalovirus (HHV-5). Frequently used as positive control. One unit allows the stimulation of 2,5 x 108 cells. You can find applications and references in our blog: FACS analysis showed: CMV-specific T cells respond to leukemia antigen >

€196.50*

More CMV Peptides & Peptide Pools

CEF (classic) Peptide Pool (>95% HPLC)

The CEF peptide pool is a lyophilized mixture of 23 peptides from cytomegalovirus (CMV), Epstein-Barr virus (EBV), and influenza virus. It consists of defined HLA class I-restricted T cell epitopes from these three viruses. The CEF peptide pool is used as a positive control to stimulate T cells. It induces secretion of e.g., IFN-γ, IL-2, and granzyme B from human CD8 T cells. The peptides of this product are supplied as trifluoracetate salts. One unit allows the stimulation of 2,5 x 108 cells.

€101.00*

CEF control Peptide Pool (>95% HPLC, advanced)

The CEF peptide pool is a lyophilized mixture of 32 peptides from cytomegalovirus (CMV), Epstein-Barr virus (EBV), and influenza virus. It consists of defined HLA class I-restricted T cell epitopes from these three viruses, and can be used as a positive control to stimulate T cells. The CEF peptide pool is used as a positive control to stimulate T cells. It induces secretion of e.g., IFN-γ, IL-2, and granzyme B from human CD8 T cells. One unit allows the stimulation of 2,5 x 108 cells.These are sequence, source and corresponding MHC class I molecule of each peptide: Sequence Source MHC class I molecule H-VSDGGPNLY-OH Influenza A HLA-A1 H-CTELKLSDY-OH Influenza A HLA-A1 H-GILGFVFTL-OH Influenza M HLA-A2 H-FMYSDFHFI-OH Influenza A HLA-A2 H-CLGGLLTMV-OH EBV LMP2A HLA-A2 H-GLCTLVAML-OH EBV BMLF1 HLA-A2 H-NLVPMVATV-OH HCMV pp65 HLA-A2 H-KTGGPIYKR-OH Influenza NP HLA-A68 H-RVLSFIKGTK-OH Influenza NP HLA-A3 H-ILRGSVAHK-OH Influenza A HLA-A3 H-RVRAYTYSK-OH EBV HLA-A3 H-RLRAEAQVK-OH EBV HLA-A3 H-SIIPSGPLK-OH Influenza M HLA-A3/A11/A6 H-AVFDRKSDAK-OH EBV EBNA 4NP HLA-A11 H-IVTDFSVIK-OH EBV HLA-A11 H-ATIGTAMYK-OH EBV HLA-A11 H-DYCNVLNKEF-OH EBV RTA HLA-A24 H-LPFDKTTVM-OH Influenza NP HLA-B7 H-RPPIFIRRL-OH EBV HLA-B7 H-ELRSRYWAI-OH Influenza NP HLA-B8 H-RAKFKQLL-OH EBV B2LF-1 HLA-B8 H-FLRGRAYGL-OH EBV EBNA 3A HLA-B8 H-QAKWRLQTL-OH EBV EBNA 3 HLA-B8 H-SDEEEAIVAYTL-OH HCMV HLA-B18 H-SRYWAIRTR-OH Influenza NP HLA-B27 H-ASCMGLIY-OH Influenza A HLA-B27 H-RRIYDLIEL-OH EBV EBNA 3C HLA-B27 H-YPLHEQHGM-OH EBV EBNA 3A HLA-B35 H-IPSINVHHY-OH CMV pp65 HLA-B35 H-EENLLDFVRF-OH EBV HLA-B44 H-EFFWDANDIY-OH HCMV HLA-B44 H-TPRVTGGGAM-OH HCMV HLA-B7 For more information and application examples, read our blog posts: "Esophagogastric adenocarcinoma: Tumor-associated antigens, immune responses and HLA-I expression" "Quality control of peptide pools in personalized cancer therapy"

€121.00*

CMV Sub Peptide Pool (>95% HPLC)

This peptide pool consists of 14 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from cytomegalovirus (CMV).

€110.50*

HCMV IE-1 199-207 (HLA-B*08:01) ( ELRRKMMYM )

ELRRKMMYM is a linear peptidic epitope (epitope ID 13133) studied as part of 55 kDa immediate-early protein 1 from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivit, tested in Tcell assays and MHC ligand assays.

From €63.50*

HCMV IE-1 248-256 (HLA-A*24:02) ( AYAQKIFKI )

AYAQKIFKI is a linear peptidic epitope (epitope ID140986) studied as part of 55 kDa immediate-early protein 1 from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €63.50*

HCMV IE-1 316-324 (HLA-A*02:01) ( VLEETSVML )

Antigen Peptide CMV IE1 HLA-A*02:01 (VLEETSVML) stimulation of human CMV IE-1(316-324)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.

From €63.50*

HCMV IE-1 378-389 (HLA-B18)

HCMV IE-1 378-389 (HLA-B18) is a HLA-B18-restricted epitope (epitope ID 57178) of Immediate early protein IE1 (UniProt:P13202) from Human Cytomegalovirus/Human herpesvirus 5. It consist of the amino acid sequence SDEEEAIVAYTL (378-389).

From €101.50*

HCMV IE-1 88-96 (HLA-B*08:01) ( QIKVRVDMV )

Antigen Peptide CMV IE-1(88-96) p (HLA-B*0801) for stimulation of T-cells. Single peptide (QIKVRVDMV) for stimulation of human CMV IE-1(88-96)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*0801 allele.

From €63.50*

HCMV IE1 184-192 (HLA-A*03:01) ( KLGGALQAK )

CMV IE1 (184-192) is a linear peptidic epitope (epitope ID 31883) with the amino acid sequence KLGGALQAK. It is studied as part of 55 kDa immediate-early protein 1 from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity and was tested in T cell assays as well as MHC ligand assays.

From €63.50*

HCMV IE1 51-59 (HLA-B*08:01) ( ELNRKMIYM )

CMV IE1-derived peptide of ELNRKMIYM covering 51-59 and B*08:01 molecule is a linear peptidic epitope (epitope ID 240792) studied as part of 55 kDa immediate-early protein 1 from Human herpesvirus 5 (Human cytomegalovirus), tested in T cell assays and MHC ligand assays.

From €63.50*

HCMV pp65 113-121 (HLA-A*24:02) ( VYALPLKML )

Antigen Peptide HCMV pp65 (113-121) HLA-A*24:02 (VYALPLKML) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. VYALPLKML is a linear peptidic epitope (epitope ID 71976) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €63.50*

HCMV pp65 16-24 (HLA-A*11:01) ( GPISGHVLK )

HCMV pp65 (16-24) peptide GPISGHVLK (HLA-A*11:01) for stimulation of human CMV pp65 (16-24)-specific CD8+ T-cells.

From €63.50*

HCMV pp65 265-275 (HLA-B*07:02) ( RPHERNGFTVL )

RPHERNGFTVL is a linear peptidic epitope (epitope ID55170) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €63.50*

HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) ( QYDPVAALF )

HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) QYDPVAALF for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. QYDPVAALF is a linear peptidic epitope (epitope ID52886) studied as part of 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays.

From €63.50*

HCMV pp65 417 – 426 (HLA-B*07:02) ( TPRVTGGGAM )

Antigen Peptide CMV pp65 - HLA-B*07:02 (TPRVTGGGAM) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. CMV pp65 (415-429) (HLA-B7) is a CEF control peptide that is derived from the Cytomegalovirus (CMV). CMV is capable of infecting a wide range of human cell types, where the body’s primary immune response to CMV is innate, and relies on inflammatory cytokines and costimulatory molecules in order to control the spread of the virus. CMV pp65 (415-429) (HLA-B7) is defined as a CEF control peptide due to its antigenic properties. Clinically, these peptides are suitable epitopes for CD8+ T cells and can be used to stimulate the release of IFNg. HLA-B7 refers to the cell HLA type that this peptide acts on.

From €126.80*

Tip

HCMV pp65 495-503 (HLA-A*02:01) ( NLVPMVATV )

Linear peptidic epitope (NLVPMVATV; epitope ID44920) for the stimulation of human CMV-specific CD8+ T-cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The synthesized peptide is presented by the MHC class I HLA-A*0201 allele. NLVPMVATV is part of the 65 kDa phosphoprotein from Human herpesvirus 5 (Human cytomegalovirus).

From €63.50*

HCMV UL138 (HLA-B*35:01)

LPLNVGLPIIGVM is a linear peptidic epitope (epitope ID 188912) studied as part of Protein UL138 from Human herpesvirus 5 (Human cytomegalovirus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assay

From €126.80*

HCMV UL40 15-23 (HLA-E) ( VMAPRTLIL )

HCMV UL40 15-23 with the amino acid sequence VMAPRTLIL is a linear peptidic epitope (epitope ID 69921) that is an important negative regulator of natural killer cell activity. The HCMV UL40 15-23 peptide is often used as positive control. HCMV UL40 15-23 is part of the immune evasion strategie of the Human Cytomegalovirus (HCMV). The virus downregulates HLA class Ia molecule expression in order to evade T cell recognition. However, a lack of surface HLA class Ia molecules triggers cytotoxicity of Natural Killer (NK) cells. To counteract this effect, the Cytomegalovirus promotes upregulation of HLA-E and provides the peptide HCMV UL40 15-23 (VMAPRTLIL), which mimics the leader sequence of HLA-Cw03 (VMAPRTLIL). When loaded onto HLA-E, this peptide conferres resistance to NK cell lysis via the CD94/NKG2A receptor. HLA-E is presenting peptides derived from self-proteomic content and peptides of pathogenic origin. VMAPRTLIL is part of the following proteins of human origin: Major histocompatibility complex, class I, C (UniProt:A0A140T9M0, A0A140T9U0, A0A0G2JH50, A0A140T912 and A0A140T9Z4) HLA class I histocompatibility antigen C alpha chain (UniProt:Q53YP1, Q5RIP0) HLA class I antigen (UniProt:Q5QT33) Isoform 2 of HLA class I histocompatibility antigen, C alpha chain (UniProt:P10321-2) See also an example comparison of our prices with the prices of other peptide manufacturers.

From €63.50*

HCMVA (IE1) Peptide Pool

Peptide pool of 120 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through 55 kDa immediate-early protein 1 (IE-1) (UniProt ID: P13202) of Human cytomegalovirus (HHV-5) frequently used as positive control One unit allows the stimulation of 2,5 x 108 cells.

€241.00*

HCMVA (IE2) Peptide Pool

Peptide pool of 143 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through 45 kDa immediate-early protein 2 (IE-2) (UniProt ID: P19893) of Human cytomegalovirus (HHV-5) frequently used as positive control One unit allows the stimulation of 2,5 x 108 cells.

€241.00*

Tip

HCMVA pp65 Peptide Pool

Peptide Pool of 138 peptides derived from a peptide scan (15mers with 11 aa overlap) through 65 kDa phosphoprotein (pp65) (UniProtKB - P06725) of Human cytomegalovirus (HHV-5). Frequently used as positive control. One unit allows the stimulation of 2,5 x 108 cells. You can find applications and references in our blog: FACS analysis showed: CMV-specific T cells respond to leukemia antigen >

€196.50*

HCMVlfl ( VMAPRTLFL )

VMAPRTLFL is a linear peptidic epitope (epitope ID99045) studied as part of HLA class I histocompatibility antigen, alpha chain G from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, MHC ligand assays

From €63.50*

HCMVos ( VMAPQSLLL )

VMAPQSLLL is a linear peptidic epitope (epitope ID 769787) studied as part of Protein UL40 (UniProt:P16780) from Human herpesvirus 5 (Human cytomegalovirus). The protein UL40 helps protect the virus from the cytotoxicity of natural killer cells. Independently of TAP, it upregulates the expression of HLA-E on the cell surface, since HLA-E inhibits the cytotoxic activity of natural killer cells. In addition, UL40 promotes the expression of the protein UL18 on the cell surface, which is also involved in evading natural killer cells.This epitope has been studied for immune reactivity, tested in T cell assays, MHC ligand assays. TAP: transporter associated with antigen processingSee also an example comparison of our prices with the prices of other peptide manufacturers

From €63.50*

Tip

HHV5 UL44 Peptide Pool

Peptide pool of 106 peptides derived from a peptide scan (15mers with 11 aa overlap) through DNA polymerase processivity factor (Uni-Prot ID P16790) of Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5). One unit allows the stimulation of 2,5 x 108 cells.

€253.50*